Key result
Elevated apoB/A1 ratio linked to ~23% higher HFrEF risk in chronic heart failure patients.
Why the study?
Apo B and apo A1 are closely linked to lipid metabolism and endothelial function, but whether circulating apoB/A1 ratio serves as a metabolic risk factor for chronic HF progression was unknown.
Does circulating apoB/A1 ratio correlate with the progression and classification of chronic heart failure?
Cross-Sectional (n=1,299)
No
Does circulating apoB/A1 ratio correlate with the progression and classification of chronic heart failure?
Answers are grounded in this paper and cite their sources.
Elevated circulating apoB/A1 ratio is associated with worsened left ventricular systolic dysfunction and serves as an independent risk factor for HFrEF and HFmrEF, particularly in patients with hypertensive heart disease or severe coronary artery disease.
Backgrounds: Apolipoprotein (apo) B and apo A1 are major protein component of low-density lipoprotein and high-density lipoprotein particles, which are closely linked to lipid metabolism, atherosclerosis, and endothelial function. We sought to investigate whether circulating apoB/A1 ratio could serve as a potential metabolic risk factor for the progression of chronic heart failure (HF). Methods Serum levels of apo B and apo A1 were measured in 1299 consecutive patients with clinical symptoms of chronic HF. Left ventricular ejection fraction (EF) and E/e’ were determined by two-dimensional echocardiography and Doppler flow imaging using standard biplane technique. The relationship of apo B/A1 ratio to classification and etiology of HF was examined. Results Overall, apoB/A1 ratio was gradually decreased from HF with reduced EF (HFrEF), HF with mid-range reduced EF (HFmrEF), to HF with preserved EF (HFpEF), and correlated negatively with left ventricular EF (r=-0.162, p < 0.001)but positively with E/e’ (r = 0.147, P < 0.001). After adjustment for conventional factors, apoB/A1 ratio remained an independent risk factor for HFrEF or HFmrEF (P < 0.05). Further analysis revealed that apoB/A1 ratio was significantly associated with HF classification in patients whose HF was caused by hypertensive heart disease or ischemic cardiomyopathy (all p < 0.05), Conclusions In patients with chronic HF, elevated circulating apoB/A1 ratio confers an increased risk for worsened left ventricular dysfunction, especially for those with hypertensive heart disease or severe coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2023) conducted a cross-sectional in Chronic heart failure (n=1,299). ApoB/A1 ratio was evaluated on Presence of HFrEF (HR 1.227, 95% CI 1.086-1.385, p=0.001). Elevated circulating apoB/A1 ratio was independently associated with an increased risk of HFrEF in patients with chronic heart failure, particularly those with hypertensive heart disease or severe coronary lesions.
Synapse has enriched 10 related papers. Consider them for comparative context: